Photo of Thomas Schön

Thomas Schön


My research concerns individualized treatment and improved diagnostics for tuberculosis and other infectious diseases.

Research focused on tuberculosis

My research is mainly focused on tuberculosis which causes about 10 million new cases per year of which about 1 million die. The immune system, bacterial resistance mechanisms to treatment and antibiotic dosing are important factors that partly determine who gets sick and who does not, but also how successful the treatment will be.

Several of my research projects in both Sweden and Ethiopia concern individualized treatment and improved diagnostics for tuberculosis and other infectious diseases, with the aim of improving the resilience of the immune system and streamlining treatment.



Latest publications in LiU DiVA


Paolo Miotto, Daniela M. Cirillo, Thomas Schön, Claudio U. Koeser (2024) The exceptions that prove the rule-a historical view of bedaquiline susceptibility Genome Medicine, Vol. 16, Article 39 Continue to DOI
Tobias Damgaard, Hanna Woksepp, Lars Brudin, Jonas Bonnedahl, Elisabet I. Nielsen, Thomas Schön, Anita Hällgren (2024) Estimated glomerular filtration rate as a tool for early identification of patients with insufficient exposure to beta-lactam antibiotics in intensive care units Infectious Diseases Continue to DOI
Sainan Wang, Lina Davies Forsman, Chunhua Xu, Haoyue Zhang, Yue Zhu, Ge Shao, Shanshan Wang, Jiayi Cao, Haiyan Xiong, Katarina Niward, Thomas Schön, Judith Bruchfeld, Limei Zhu, Jan-Willem Alffenaar, Yi Hu (2024) Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment International Journal of Infectious Diseases, Vol. 140, p. 62-69 Continue to DOI
Sushil Pandey, Catherine Vilcheze, Jim Werngren, Arnold Bainomugisa, Mikael Mansjo, Ramona Groenheit, Paolo Miotto, Daniela M. Cirillo, Christopher Coulter, Alain R. Baulard, Thomas Schön, William R. Jacobs Jr, Kamel Djaout, Claudio U. Koser (2024) Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy, Vol. 68, Article e0109623 Continue to DOI
John Walles, Niclas Winqvist, Stefan R. Hansson, Erik Sturegard, Haitham Baqir, Anna Westman, Torbjoern Kjerstadius, Thomas Schön, Per Bjorkman (2024) Pregnancy Outcomes in Women Screened for Tuberculosis Infection in Swedish Antenatal Care Clinical Infectious Diseases, Vol. 78, p. 125-132 Continue to DOI